About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
The University of Kansas Cancer Center
https://www.kucancercenter.org/
2023 Multidisciplinary Oncology Review
2022
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
2022 Post San Antonio Review
Videos
2021
2021 Virtual KU Hematology and Medical Oncology Review
2021 Post San Antonio Review
2021 KUMC Virtual Multidisciplinary Oncology Review
2020
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
2020 ASCO Highlights
2019
2019 Post San Antonio Breast Cancer Review
ASH 2019 Review: Current Updates in Hematologic Diseases
2019 Lung Cancer and Head & Neck Cancer Symposium
Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Event
2018
ASH: Current Updates in Hematologic Diseases
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
ASH 2019 Update on the Higher-Risk MDS: HMA & HCT - Need to Focus on Response Duration and Overall Survival, Goals of Therapy Should Reflect Goals of Patient
By
KU ASH 2019 Review: Current Updates in Hematologic Diseases
FEATURING
Mikkael Sekeres
By
KU ASH 2019 Review: Current Updates in Hematologic Diseases
FEATURING
Mikkael Sekeres
48 views
February 13, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
ASH 2019 Review: Current Updates in Hematologic Diseases
13:23
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update on MDS: Definitions and the Notion of Risk
Feat.
M. Sekeres
14:52
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update on Low-Risk MDS: Ameliorating Anemia
Feat.
M. Sekeres
05:28
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update on Low-Risk MDS: Tackling Thrombocytopenia / Modifyi…
Feat.
M. Sekeres
09:05
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update on the Higher-Risk MDS: HMA & HCT - Need to Focu…
Feat.
M. Sekeres
06:19
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update: Adding Targeted Agents to Intensive Therapy in AML …
Feat.
H. Male
09:18
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update: Understanding the Leukemia Mutational Profile in a …
Feat.
H. Male
10:05
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update: CC-486 Demonstrated Improvement in OS and RFS in Ma…
Feat.
H. Male
36:19
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update on Myeloproliferative Neoplasms: CPI-0610 (BET Inhib…
Feat.
R. Hoffman
20:32
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update on the Bone Marrow Procedures with a Dry Tap: KUH Dr…
Feat.
J. Woodroof
